Journal of Current Glaucoma Practice

Register      Login

VOLUME 6 , ISSUE 1 ( 2012 ) > List of Articles

NEW DEVICE

Ocular Response Analyzer

Sushmita Kaushik, Surinder Singh Pandav

Citation Information : Kaushik S, Pandav SS. Ocular Response Analyzer. J Curr Glaucoma Pract 2012; 6 (1):17-19.

DOI: 10.5005/jp-journals-10008-1103

License: CC BY 4.0

Published Online: 00-04-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Until recently, corneal biomechanical properties could not be measured in vivo. The ocular response analyzer is a new, noninvasive device that analyses corneal biomechanical properties simply and rapidly. The ORA allows cornea compensated IOP measurements and can estimate corneal hysteresis (CH) and corneal resistance factor (CRF). It is designed to improve the accuracy of IOP measurement by using corneal biomechanical data to calculate a biomechanically adjusted estimate of intraocular pressure. This review critically evaluates the technology and its implications in current day glaucoma management.


PDF Share
  1. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122(4):477-85.
  2. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122(4):532-38.
  3. Pizzarello L, Abiose A, Ffytche T, et al. Vision 2020: The right to sight: A global initiative to eliminate avoidable blindness. Arch Ophthalmol 2004;122(4):615-20.
  4. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120(6):701-13, discussion 829-30.
  5. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108(11):1943-53.
  6. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial. Arch Ophthalmol 2003;121(1):48-56.
  7. Collaborative initial normal-tension glaucoma study group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-97.
  8. AGIS (advanced glaucoma intervention study) investigators. The advanced glaucoma intervention study (AGIS): The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130(4):429-40.
  9. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial. Arch Ophthalmol 2002;120(10):1268-79.
  10. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: A review and metaanalysis approach. Surv Ophthalmol 2000;44:367-408.
  11. Liu J, Roberts CJ. Influence of corneal biomechanical properties on intraocular pressure measurement: Quantitative analysis. J Cataract Refract Surg 2005;31:146-55.
  12. Medeiros FA, Weinreb RN. Evaluation of the influence of corneal biomechanical properties on intraocular pressure measurements using the ocular response analyzer. J Glaucoma 2006;15(5):364-70.
  13. Luce DA. Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg 2005;31:156-62.
  14. Woo SL, Kobayashi AS, Schlegel WA, Lawrence C. Nonlinear material properties of intact corneal and sclera. Exp Eye Res 1972;14(1):29-39.
  15. Wells AP, Garway-Heath DF, Poostchi A, Wong T, Chan KC, Sachdev N. Corneal hysteresis but not corneal thickness correlates with optic nerve surface compliance in glaucoma patients. Invest Ophthalmol Vis Sci 2008;49(8):3262-68.
  16. Congdon NG, Broman AT, Bandeen-Roche K, et al. Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol 2006;141(5):868-75.
  17. Downs JC, Suh JK, Thomas KA, et al. Viscoelastic material properties of the peripapillary sclera in normal and early-glaucoma monkey eyes. Invest Ophthalmol Vis Sci 2005;46(2):540-46.
  18. Sun L, Shen M, Wang J, et al. Recovery of corneal hysteresis after reduction of intraocular pressure in chronic primary angleclosure glaucoma. Am J Ophthalmol 2009;147:1061-66.
  19. Neuburger M, Bohringer D, Reinhard T, Jordan J. Recovery of corneal hysteresis after reduction of intraocular pressure in chronic primary angle-closure glaucoma. Am J Ophthalmol 2009;149(4):687-88.
  20. Shimmyo M. Recovery of corneal hysteresis after reduction of intraocular pressure in chronic primary angle-closure glaucoma. Am J Ophthalmol 2009;148(4):623.
  21. Kaushik S, Pandav SS, Banger A, Agarwal K. Relationship between corneal biomechanical properties, central corneal thickness and IOP across the glaucoma spectrum. Am J Ophthalmology. In Press.
  22. Lim R, Goldberg I. Glaucoma in the Twenty-First Century. In: Schacknow PN, Samples JR (Eds). The Glaucoma Book: A Practical, Evidence-Based Approach to Patient Care (1st ed). New York: Springer 2010;18-19.
  23. Severn P, Fraser S, Finch T, May C. Which quality of life score is best for glaucoma patients and why? BMC Ophthalmology [serial on internet]. 2008 [Cited on 2011 March 27]; 8:2. Available from: http://www.biomedcentral.com/1471-2415/8/2.
  24. Barber BL, Strahlman ER, Laibovitz R, Guess HA, Reines SA. Validation of a questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology 1997;104:334-42.
  25. Parrish RK. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Am Ophthalmol Soc 1996;94:919-1028.
  26. Tripop S, Pratheepawanit N, Asawaphureekorn S, Anutangkoon W, Inthayung S. Health related quality of life instruments for glaucoma: A comprehensive review. J Med Assoc Thai 2005;88(Suppl 9):155-62.
  27. Bremond-Gignac D, Tixier J, Missotten T, Laroche L, Beresniak A. Evaluation of the quality of life in ophthalmology. Presse Med 2002;31(34):1607-12.
  28. Singh K, Shrivastava A. Medical management of glaucoma: Principles and practice. Indian J Ophthalmol 2011;59(Suppl 1):88-92.
  29. Aspinall PA, Johnson ZK, Brice R, Vickers A, Montarzino A, Azuara-Blanco A. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci 2008;49(5):1907-15.
  30. Kotsiomiti E, Tzialla A, Hatjivasiliou K. Accuracy and stability of impression materials subjected to chemical disinfection—a literature review. J Oral Rehabil. 2008; 35(4):291-9.
  31. Gountenoudis M. Bestimmung der Randspaltbreite hochgoldhaltiger Restaurationen unter Berücksichtigung der Präparationsform der Abformmethodik und des Abformmaterials [dissertation]. Giessen: Justus-Liebig-Universität; 2003. p. 14-7.
  32. Boeckler AF, Stadler A, Setz JM. The significance of marginal gap and overextension measurement in the evaluation of the fit of complete crowns. J Contemp Dent Pract. 2005; 6(4):26-37.
  33. Donath K, Roth K. Histologischmorphometrische Studie zur Bestimmung des zervikalen Randschlusses von Einzelevaluation und Pfeilerkronen. [Histologic-morphometric studies to determine the cervical marginal fit of singe and pontic crowns.] Z Stomatol. 1987; 84(2):53-73.
  34. Gassino G, Barone Monfrin S, Scanu M, Spina G, Preti G. Marginal adaptation of fixed prosthodontics: a new in vitro 360-degree external examination procedure. Int J Prosthodont. 2004; 17(2):218-23.
  35. Dreyer-Jørgensen K. Prüfungsergebnisse zahnärztlicher Gussverfahren. Dtsch Zahnärztl Z. 1958;13:461–9.
  36. Christensen GJ. Marginal fit of gold inlay castings. J Prosthet Dent. 1966; 16(2): 297-305.
  37. McLean JW, von Fraunhofer JA. The estimation of cement film thickness by an in vivo technique. Br Dent J. 1971; 131(3):107-11.
  38. Kim KM, Lee JS, Kim KN, Shin SW. Dimensional changes of dental impression materials by thermal changes. J Biomed Mater Res. 2001; 58(3):217-20.
  39. Haque MM, Alsareii SA. A review of the therapeutic effects of using miswak (Salvadora persica) on oral health. Saudi Med J 2015 May;36(5):530-543.
  40. Ramachandra JA, Nihal NK, Nagarathna C, Vora MS. Root canal irrigants in primary teeth. World J Dent 2015 Oct-Dec;6(3):229-234.
  41. Sahota MBK, Ahmed K. A review on a life of spice turmeric (curcuma longa). Sci Int (Lahore) 2015;28(1):375-378.
  42. Rai D, Singh JK, Roy N, Panda D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochemical J 2008 Feb;410(1):147-155.
  43. Sinha DJ, Vasudeva A, Gowhar O, Garg P, Sinha A, Prakash P. Comparison of antimicrobial efficacy of Propolis, Azadirachta indica (Neem), Melaleuca alternifolia (Tea tree oil), Curcuma longa (Turmeric) and 5% Sodium hypochlorite on Candida albicans biofilm formed on tooth substrate: An in-vitro study. J Pharm Biomed Sci 2015 Jun;5(6):469-474.
  44. Mandroli PS, Bhat K. An in-vitro evaluation of antibacterial activity of curcumin against common endodontic bacteria. J Appl Pharm Sci 2013 Oct;3(10):106-108.
  45. Damre PG. Comparative evaluation of antimicrobial activity of herbal vs chemical root canal irrigants against E. Faecalis—an in vitro study. Int J Adv Res 2015 Sep;3(9):1563-1572.
  46. Kumar H. An in vitro evaluation of the antimicrobial efficacy of Curcuma longa, Tachyspermum ammi, chlorhexidine gluconate, and calcium hydroxide on Enterococcus faecalis. J Conserv Dent 2013 Mar;16(2):144-147.
  47. Andersson M, Carlsson L, Persson M, Bergman B. Accuracy of machine milling and spark erosion with a CAD/CAM system. J Prosthet Dent 1996 Aug;76(2):187-193.
  48. Henkel GL. A comparison of fixed prostheses generated from conventional vs digitally scanned dental impressions. Compend Contin Educ Dent 2007 Aug;28(8):422-424, 426-428, 430-431.
  49. Speaker MG, Arentsen JJ, Laibson PR. Long-term survival of large diameter penetrating keratoplasties for keratoconus and pellucid marginal degeneration. Acta Ophthalmol Suppl 1989;192:17-19.
  50. Jinabhai A, Radhakrishnan H, O'Donnell C. Pellucid corneal marginal degeneration: a review. Contact Lens Anterior Eye 2011 Apr;34(2):56-63.
  51. Kaushal S, Jhanji V, Sharma N, Tandon R, Titiyal JS, Vajpayee RB. “Tuck In” lamellar keratoplasty (TILK) for corneal ectasias involving corneal periphery. Br J Ophthalmol 2008 Feb;92(2):286-290.
  52. Schanzlin DJ, Sarno EM, Robin JB. Crescentic lamellar keratoplasty for pellucid marginal degeneration. Am J Ophthalmol 1983 Aug;96(2):253-254.
  53. Kremer I, Sperber LT, Laibson PR. Pellucid marginal degeneration treated by lamellar and penetrating keratoplasty. Arch Ophthalmol 1993 Feb;111(2):169-170.
  54. Rasheed K, Rabinowitz YS. Surgical treatment of advanced pellucid marginal degeneration. Ophthalmology 2000 Oct;107(10):1836-1840.
  55. Jabbarvand M, Hashemian H, Khodaparast M, Hassanpour N, Mohebbi M. Intrastromal lamellar keratoplasty in patients with pellucid marginal degeneration. J Cataract Refract Surg 2015 Jan;41(1):2-8.
  56. MacLean H, Robinson LP, Wechsler AW. Long-term results of corneal wedge excision for pellucid marginal degeneration. Eye (Lond) 1997;11(Pt 5):613-617.
  57. Javadi MA, Karimian F, Hosseinzadeh A, Noroozizadeh HM, Sa'eedifar MR, Rabie HM. Lamellar crescentic resection for pellucid marginal corneal degeneration. J Refract Surg 2004 Mar-Apr;20(2):162-165.
  58. Fronterre A, Portesani GP. Epikeratoplasty for pellucid marginal corneal degeneration. Cornea 1991 Sep;10(5):450-453.
  59. Ramez Barbara J, Barbara R, Zadok D, et al. Collagen Corneal Cross-Linking followed by Intac Implantation in a Case of Post-PRK Ectasia. Int J Keratoco Ectatic Corneal Dis 2012;1(1):68-72.
  60. Yeung SN, Ku JYF, Lichtinger A, Low SAW, Kim P, Rootman DS. Efficacy of single or paired intrastromal corneal ring segment implantation combined with collagen crosslinking in keratoconus. J Cataract Refract Surg 2013 Aug;39(8):1146-1151.
  61. Kiliç A, Kamburoglu G, Akinci A. Riboflavin injection into the corneal channel for combined collagen crosslinking and intrastromal corneal ring segment implantation. J Cataract Refract Surg 2012 May;38(5):878-883.
  62. Ferenczy PA, Dalcegio M, Koehler M, Pereira TS, Moreira H, Bugmann ML. Femtosecond-assisted intrastromal corneal ring implantation for keratoconus treatment: a comparison with crosslinking combination. Arq Bras Oftalmol 2015 Mar-Apr;78(2):76-81.
  63. Baikoff G, Joly P. Comparison of minus power anterior chamber intraocular lenses and myopic epikeratoplasty in phakic eyes. Refract Corneal Surg 1990 Jul-Aug;6(4):252-260.
  64. Baikoff G. Phakic anterior chamber intraocular lenses. Int Ophthalmol Clin 1991 Winter;31(1):75-86.
  65. Fechner PU, Worst JG. A new concave intraocular lens for the correction of myopia. Eur J Implant Refract Surg 1989 Mar;1(1):41-43.
  66. Brauweiler PH, Wehler T, Busin M. High incidence of cataract formation after implantation of a silicone posterior chamber lens in phakic, highly myopic eyes. Ophthalmology 1999 Sep;106(9):1651-1655.
  67. Zhang X, Tao X-C, Li Z-W, Zhou W-Y, Ma P, Zhang C-X, Wang Y-M, Mu G-Y. Combining corneal crosslinking and phakic toric implantable collamer lenses for the treatment of keratectasia: a case report. Exp Ther Med 2016 Sep;12(3):1495-1498.
  68. Cakir H, Utine CA. Combined kerarings and Artisan/Artiflex IOLs in keratectasia. J Refract Surg 2011 Feb;27(2):119-126.
  69. Moshirfar M, Fenzl CR, Meyer JJ, Neuffer MC, Espandar L, Mifflin MD. Simultaneous and sequential implantation of Intacs and verisyse phakic intraocular lens for refractive improvement in keratectasia. Cornea 2011 Feb;30(2):158-163.
  70. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003 Jul;110(7):1396-1402.
  71. McAllum PJ, Segev F, Herzig S, Rootman DS. Deep anterior lamellar keratoplasty for post-LASIK ectasia. Cornea 2007 May;26(4):507-511.
  72. Villarrubia A, Perez-Santonja JJ, Palacin E, Rodriguez-Ausin PP, Hidalgo A. Deep anterior lamellar keratoplasty in post-laser in situ keratomileusis keratectasia. J Cataract Refract Surg 2007 May;33(5):773-778.
  73. Grewal S, Laibson PR, Cohen EJ, Rapuano CJ. Acute hydrops in the corneal ectasias: Associated factors and outcomes. Trans Am Ophthalmol Soc 1999;97:187-98.
  74. Koenig SB, Smith RW. Keratoconus and corneal hydrops associated with compulsive eye rubbing. Refract Corneal Surg 1993;9:383-84.
  75. Mashor RS, Kumar NL, Ritenour RJ, Rootman DS. Keratoconus caused by eye rubbing in patients with Tourette syndrome. Can J Ophthalmol 2011;46:83-86.
  76. Kandarakis A, Karampelas M, Soumplis V, et al. A case of bilateral self-induced keratoconus in a patient with Tourette syndrome associated with compulsive eye rubbing: Case report. BMC Ophthalmol 2011;11:28.
  77. Coyle JT. Keratoconus and eye rubbing. Am J Ophthalmol 1984;97:527-28.
  78. Gritz DC, McDonnell PJ. Keratoconus and ocular massage. Am J Ophthalmol 1988;106:757-58.
  79. Rahi A, Davies P, Ruben M, et al. Keratoconus and coexisting atopic disease. Br J Ophthalmol 1977;61:761-64.
  80. Besancon G, Baikoff G, Deneux A, et al. Preliminary note on the psychological and mental status of patients with keratoconus. Bull Soc Ophtalmol Fr 1980;80:441-43.
  81. Copeman PW. Eczema and keratoconus. Br Med J 1965;2: 977-79.
  82. Mannis MJ, Morrison TL, Zadnik K, et al. Personality trends in keratoconus. An analysis. Arch Ophthalmol 1987;105:798-800.
  83. Swartz NG, Cohen EJ, Scott DG, et al. Personality and keratoconus. CLAO J 1990;16:62-64.
  84. Gasset AR, Hinson WA, Frias JL. Keratoconus and atopic diseases. Ann Ophthalmol 1978;10:991-94.
  85. Kaya V, Karakaya M, Utine CA, et al. Evaluation of the corneal topographic characteristics of keratoconus with orbscan II in patients with and without atopy. Cornea 2007;26:945-48.
  86. Galin MA, Berger R. Atopy and keratoconus. Am J Ophthalmol 1958;45:904-06.
  87. Roth HL, Keirland RR. The natural history of atopic dermatitis. A 20-year follow-up study. Arch Dermatol 1964;89:209-14.
  88. Lowell FC, Carroll JM. A study of the occurrence of atopic traits in patients with keratoconus. J Allergy 1970;46:32-39.
  89. Nemet AY, Vinker S, Bahar I, Kaiserman I. The association of keratoconus with immune disorders. Cornea 2010;29:1261-64.
  90. Buddi R, Lin B, Atilano SR, et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002;50: 341-51.
  91. Kenney MC, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye 2003;26(3):139-46.
  92. Behndig A, Karlsson K, Johansson BO, et al. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci 2001;42:2293-96.
  93. Podskochy A, Fagerholm P. The expression of Fas ligand protein in ultraviolet-exposed rabbit corneas. Cornea 2002;21:91-94.
  94. Newkirk KM, Chandler HL, Parent AE, et al. Ultraviolet radiation-induced corneal degeneration in 129 mice. Toxicol Pathol 2007;35:819-26.
  95. Pettenati MJ, Sweatt AJ, Lantz P, et al. The human cornea has a high incidence of acquired chromosome abnormalities. Hum Genet 1997;101:26-29.
  96. Snibson GR. Collagen cross-linking: A new treatment paradigm in corneal disease—a review. Clin Experiment Ophthalmol 2010;38:141-53.
  97. Spoerl E, Raiskup-Wolf F, Kuhlisch E, Pillunat LE. Cigarette smoking is negatively associated with keratoconus. J Refract Surg 2008;24:S737-40.
  98. Rabinowitz YS, Nesburn AB, McDonnell PJ. Videokeratography of the fellow eye in unilateral keratoconus. Ophthalmology 1993;100:181-86.
  99. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990;9:529-54.
  100. Moodaley LC, Woodward EG, Liu CS, Buckley RJ. Life expectancy in keratoconus. Br J Ophthalmol 1992;76:590-91.
  101. Honein MA, Dawson AL, Petersen EE, Jones AM, Lee EH, Yazdy MM, Ahmad N, Macdonald J, Evert N, Bingham A, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017 Jan 3;317(1):59-68.
  102. Chervenak FA, Jeanty P, Cantraine F, Chitkara U, Venus I, Berkowitz RL, Hobbins JC. The diagnosis of fetal microcephaly. Am J Obstet Gynecol 1984 Jul 1;149(5):512-517.
  103. Papageorghiou AT, Thilaganathan B, Bilardo CM, Ngu A, Malinger G, Herrera M, Salomon LJ, Riley LE, Copel JA. ISUOG Interim Guidance on ultrasound for Zika virus infection in pregnancy: information for healthcare professionals. Ultrasound Obstet Gynecol 2016 Apr;47(4):530-532.
  104. Chibueze EC, Parsons AJ, Lopes KD, Yo T, Swa T, Nagata C, Horita N, Morisaki N, Balogun OO, Dagvadorj A, et al. Diagnostic accuracy of ultrasound scanning for prenatal microcephaly in the context of Zika virus infection: a systematic review and meta-analysis. Sci Rep 2017 May 23;7(1):2310.
  105. Cordeiro MT. Zika virus: laboratory diagnosis. In: Zika in focus. Springer International Publishing; 2017. pp. 59-62.
  106. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, et al. Zika virus associated with microcephaly. N Engl J Med 2016 Mar 10;374(10):951-958.
  107. Zare Mehrjardi M, Keshavarz E, Poretti A, Hazin AN. Neuroimaging findings of Zika virus infection: a review article. Jpn J Radiol 2016 Dec;34(12):765-770.
  108. Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, Bispo de Filippis AM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016 Jan;47(1):6-7.
  109. Araujo AQ, Silva MT, Araujo AP. Zika virus-associated neurological disorders: a review. Brain 2016;139(8):2122-2130.
  110. Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016 Dec 15;375(24):2321-2334.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.